search
Back to results

Effects of BIONESS in Rehabilitation of Stroke (EFES-BIO-SEP)

Primary Purpose

Stroke

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Bioness-300
Sponsored by
LMU Klinikum
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adults between the ages of 18 and 75
  • Inadequate ankle dorsiflexion during the swing phase of gait, resulting in inadequate limb clearance
  • Medically stable for at least one week following the last episode of stroke
  • Stable medication for four weeks
  • Adequate cognitive and communication function to give informed consent, understand the training instructions, use the device, and give adequate feedback
  • Ability to walk with or without an assistive device (except parallel bars) at least 10 meters

Exclusion Criteria:

  • • Lower motor neuron injury with inadequate response to stimulation

    • History of falls greater than once a week
    • Severe cardiac disease such as myocardial infarction, congestive heart failure, or a demand pacemaker
    • Patients who have other electrical stimulation devices implemented
    • Patients with epilepsy and with autoimmune diseases

Sites / Locations

  • Neurological Clinic Medicalpark Bad Feilnbach

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Open labele BIONESS-Training

Arm Description

Four-week therapeutic treatment of foot drop with the electrical stimulation device Bioness L300. This treatment will be performed five times a week for at least 30 minutes

Outcomes

Primary Outcome Measures

SEP measurement
in improving pathological latencies and / or amplitudes of somatosensory evoked potentials (SEPs) • N35, P40, N50 (lower limb / tibial nerve) amplitude of somatosensory evoked potential [ Time Frame: Change from baseline at 4 weeks]

Secondary Outcome Measures

Motor score improvement
• Dorsal flexion/plantar extension of the ankle strength will be measured by Janda's classification of muscle imbalance patterns (Force produced by voluntary dorsiflexion). [ Time Frame: Change from baseline at 4 weeks]

Full Information

First Posted
February 17, 2021
Last Updated
March 14, 2023
Sponsor
LMU Klinikum
Collaborators
Peter Young Neurological Clinic Medicalpark Bad Feilnbach, Germany
search

1. Study Identification

Unique Protocol Identification Number
NCT04767360
Brief Title
Effects of BIONESS in Rehabilitation of Stroke
Acronym
EFES-BIO-SEP
Official Title
Short-term Therapeutic Effects of Functional Electrical Stimulation Device Bioness L300 on the Somatosensory Cortical Representation in the Rehabilitation of Patients After Stroke
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Completed
Study Start Date
February 10, 2021 (Actual)
Primary Completion Date
October 19, 2021 (Actual)
Study Completion Date
December 12, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
LMU Klinikum
Collaborators
Peter Young Neurological Clinic Medicalpark Bad Feilnbach, Germany

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
A four-weeks randomized clinical two-period crossover-design study will be conducted. Each patient will be randomized in a two separate consecutive treatment periods (Parallel Group Design). "Group A" will be treated with functional electrical stimulation (FES) and a second "Gruppe B" will be treated without FES for two weeks. After this period Group A and Group B will switched.
Detailed Description
Prediction of motor recovery in the upper-limb (UL) / lower-limb (LL) in patients with stroke is generally based on clinical examination. However, according to former studies neurophysiological measures may also have a predictive value. In the acute phase, the combination of the motor score and SEPs are best predictive of outcome. Neurophysiological measures alone are of limited value in predicting long term outcome. However, predictive accuracy is substantially improved through the combined use of both of these measures and clinical variables. A four-weeks randomized clinical two-period crossover-design study will be conducted. Each patient will be randomized in a two separate consecutive treatment periods (Parallel Group Design). "Group A" will be treated with functional electrical stimulation (FES) and a second "Gruppe B" will be treated without FES for two weeks. After this period Group A and Group B will switched.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Sequential Assignment
Model Description
clinical sequential two-period crossover-design study
Masking
None (Open Label)
Allocation
N/A
Enrollment
32 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Open labele BIONESS-Training
Arm Type
Other
Arm Description
Four-week therapeutic treatment of foot drop with the electrical stimulation device Bioness L300. This treatment will be performed five times a week for at least 30 minutes
Intervention Type
Device
Intervention Name(s)
Bioness-300
Intervention Description
Therapeutic treatment of foot drop with the electrical stimulation device Bioness L300.
Primary Outcome Measure Information:
Title
SEP measurement
Description
in improving pathological latencies and / or amplitudes of somatosensory evoked potentials (SEPs) • N35, P40, N50 (lower limb / tibial nerve) amplitude of somatosensory evoked potential [ Time Frame: Change from baseline at 4 weeks]
Time Frame
4 weeks
Secondary Outcome Measure Information:
Title
Motor score improvement
Description
• Dorsal flexion/plantar extension of the ankle strength will be measured by Janda's classification of muscle imbalance patterns (Force produced by voluntary dorsiflexion). [ Time Frame: Change from baseline at 4 weeks]
Time Frame
4 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adults between the ages of 18 and 75 Inadequate ankle dorsiflexion during the swing phase of gait, resulting in inadequate limb clearance Medically stable for at least one week following the last episode of stroke Stable medication for four weeks Adequate cognitive and communication function to give informed consent, understand the training instructions, use the device, and give adequate feedback Ability to walk with or without an assistive device (except parallel bars) at least 10 meters Exclusion Criteria: • Lower motor neuron injury with inadequate response to stimulation History of falls greater than once a week Severe cardiac disease such as myocardial infarction, congestive heart failure, or a demand pacemaker Patients who have other electrical stimulation devices implemented Patients with epilepsy and with autoimmune diseases
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Benedikt Schoser, MD
Organizational Affiliation
Friedrich-Baur-Institute, Dep. of Neurology LMU Klinikum Munich Germany
Official's Role
Principal Investigator
Facility Information:
Facility Name
Neurological Clinic Medicalpark Bad Feilnbach
City
Bad Feilnbach
State/Province
Bavaria
ZIP/Postal Code
83075
Country
Germany

12. IPD Sharing Statement

Plan to Share IPD
No
Links:
URL
http://www.medicalpark.de
Description
homepage Medicalpark Clinics

Learn more about this trial

Effects of BIONESS in Rehabilitation of Stroke

We'll reach out to this number within 24 hrs